Research Progress of Nano Targeted Drug Delivery System in Treatment and Diagnosis of Oral Squamous Cell Carcinoma.

doi:10.13701/j.cnki.kqyxyj.2018.12.004

Abstract

Abstract: Oral squamous cell carcinoma is the most common malignant tumor in the oral and maxillofacial region.The surgical treatment is the routine treatment strategy.Nevertheless, there exist several risks and the reduced life quality after treatment.The conventional chemotherapy and radiotherapy will impair normal tissue in high concentration.Nano targeted drug delivery system is a new treatment technology with aim to treat malignant tumors accurately and improve therapeutic effect.This technology has made great progress in other parts of human body, but not enough in the area of oral squamous cell carcinoma.As treatment technology is developing rapidly, how to improve the efficiency and safety about and monitor the result of nano targeted drug delivery have become a new challenge, whichcontributes to the evaluating of instant therapeutic effect.In this paper, the progress of nano targeted drug delivery system in diagnosis and treatment of oral squamous cell carcinoma in recent years were reviewed.

Key words: Oral squamous cell carcinoma, Nano targeted, Drug delivery system

YAO Meng-huan, WANG Tie-mei, LIN Zi-tong. Research Progress of Nano Targeted Drug Delivery System in Treatment and Diagnosis of Oral Squamous Cell Carcinoma.[J]. Journal of Oral Science Research, 2018, 34(12): 1277-1280.

References

[1] Zhong LP, Zhang CP, Ren GX, et al. Randomized phase Ⅲ trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma [J]. J Clin Oncol, 2012, 31(6)∶744-751
[2] 曹雨庵. 我国口腔鳞癌的治疗现状[J]. 实用肿瘤杂志, 2012, 27(2)∶109-112
[3] Bahrami B, Hojjatfarsangi M, Mohammadi H, et al. Nanoparticles and targeted drug delivery in cancer therapy [J]. Immunol Lett, 2017, 190∶64-83
[4] 林辉.口腔癌的综合治疗[J].世界临床医学,2016,10(22)∶121-122
[5] Warnakulasuriya S . Living with oral cancer: Epidemiology with particular reference to prevalence and life-style changes that influence survival [J]. Oral Oncol, 2010, 46(6)∶407-410
[6] 肖燕,张沛沛,李文鹿,等.口腔癌患者健康相关生活质量及其影响因素调查[J].口腔医学研究,2016,32(5)∶478-482
[7] Calixto G, Bernegossi J, Fonsecasantos B, et al. Nanotechnology-based drug delivery systems for treatment of oral cancer: a review [J]. Int J Nanomedicine,2014,8(9)∶3719-3735
[8] Virupakshappa B. Applications of nanomedicine in oral cancer [J]. Oral Health Dent Manag, 2012, 11(2)∶62-68
[9] 崔敬敬, 金光玉, 夏雷, 等. 超顺磁性氧化铁纳米粒在磁共振成像和药物传递系统中的应用[J]. 国际药学研究杂志, 2015, 42(5)∶601-605
[10] 崔敏毅,蔡华崧,董帜,等.叶酸介导超顺磁性氧化铁纳米颗粒标记舌癌细胞的磁共振成像研究[J].中华口腔医学研究杂志:电子版,2015,9(2)∶18-21
[11] Somaia Said Abd El-Karim, Magdy Ibrahim El-Zahar,Manal Mohamed Anwar. Nanotechnology in cancer diagnosis and treatment [J].J Pharmacy Pharmacol,2015,3(7)∶299-315
[12] Reddy PS, Ramaswamy P, Sunanda C, et al. Role of gold nanoparticles in early detection of oral cancer [J]. J Indian Academ Oral Med Radiol, 2010, 22∶30-33
[13] Ahn S, Jung SY, Lee SJ, et al. Gold nanoparticle contrast agents in advanced X-ray imaging technologies[J]. Molecules, 2013, 18(5)∶5858-5890
[14] Yang K, Zhang FJ, Tang H, et al. In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice [J]. Int J Nanomedicine, 2011, 6∶1739-1745
[15] 黄桂林.选择性动脉灌注化疗在口腔癌治疗中的进展[J].口腔颌面外科杂志,2015,25(5)∶317-320
[16] Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy [J]. Adv Drug Deliv Rev, 2012, 64∶206-212
[17] 赵晶晶,沈灵佳,周建平,等.纳米靶向给药系统载体材料的研究进展[J].药学进展,2015,39(3)∶161-169
[18] 韩金荣,张林西.姜黄素抗肿瘤作用机制[J].国际肿瘤学杂志,2013,40(11)∶823-826
[19] Mazzarino L, Loch-Neckel G, Bubniak Ldos S, et al. Curcumin-loaded chitosan-coated nanoparticles as a new approach for the local treatment of oral cavity cancer [J]. J Nanosci Nanotechnol, 2015, 15(1)∶781-791
[20] Singh SP, Sharma M, Gupta PK. Evaluation of phototoxic effects of curcumin loaded in organically modified silica nanoparticles in tumor spheroids of oral cancer cells [J]. BioNanoSci, 2014, 5(1)∶10-21
[21] Yu D, Wang A, Huang H, et al. PEG-PBLG nanopar-ticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma [J]. Nanomed, 2008, 3(6)∶813-821
[22] Bellis SL. Advantages of RGD peptides for directing cell association with biomaterials [J]. Biomaterials,2011,32(18)∶4205-4210
[23] Li Q , Wen Y , You X , et al. Development of reactive oxygen species (ROS)-responsive nanoplatform for targeted oral cancer therapy [J]. J Mater Chem B,2016,4(27)∶4675-4682
[24] Miao L, Liu C, Ge J, et al. Antitumor effect of TRAIL on oral squamous cell carcinoma using magnetic nanoparticle-mediated gene expression. [J]. Cell Biochem Biophys, 2014, 69(3)∶663-672
[25] Zhao H, Feng H, Liu D, et al. Self-assembling monomeric nucleoside molecular nanoparticles loaded with 5-FU enhancing therapeutic efficacy against oral cancer [J]. Acs Nano, 2015, 9(10)∶9638-9651
[26] Eifler AC, Thaxton CS . Nanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case study [J]. Methods Mol Biol, 2011, 726∶325-328